Difference between revisions of "MSK Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
(Meetings)
(Meetings)
 
Line 12: Line 12:
  
 
'''Approved call summaries:'''
 
'''Approved call summaries:'''
 +
*[[Media:2020_09-22_QIBA_MSK_BC_Call_Summary-FINAL.pdf|September 22, 2020]]
 
*[[Media:2020_07-28_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|July 28, 2020]]
 
*[[Media:2020_07-28_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|July 28, 2020]]
 
*[[Media:2020_06-23_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|June 23, 2020]]
 
*[[Media:2020_06-23_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|June 23, 2020]]
*[[Media:2020_05-26_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|May 26, 2020]]
 
  
 
'''''[[MSK Biomarker Committee Call Summaries Archive]]'''''
 
'''''[[MSK Biomarker Committee Call Summaries Archive]]'''''

Latest revision as of 16:03, 27 October 2020

Co-chairs: Xiaojuan Li, PhD; Thomas M. Link, MD, PhD
RSNA Staff Support: Susan Stanfa

The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK.

MSK Profile-Wiki Announcement-2.PNG


Meetings

Approved call summaries:

MSK Biomarker Committee Call Summaries Archive

Working Documents

  • QIBA MSK Profile 2020-01-28: MR-based cartilage compositional biomarkers (T1ρ, T2) for risk prediction, early diagnosis and monitoring of treatment of degenerative joint disease

Statistical Reference Documents

Workflow Documents

Reference Materials